As an innovative pioneer in intelligent surgical robotics, AGIBOT is dedicated to addressing unmet clinical needs in surgical fields. With the surgical robot as the core platform, the company builds its product pipeline around four enabling technologies — specialized instruments, visualization and imaging, energy systems, and artificial intelligence — committed to making Intelligent Surgical Solutions more innovative, more practical, and more accessible.

Founded in September 2020 and headquartered in Suzhou, China, AGIBOT unites a medtech-integrated team of surgical robotics experts and multidisciplinary professionals. Our full-chain development capabilities span from conceptual design to system integration, supported by a technological innovation platform covering mechanical, electrical, optical, computational, software, and medical engineering disciplines.

The AGIBOT Endoscopic Surgical System has obtained NMPA clearance, fully covering four core departments: Urology, Gynecology, General Surgery, and Thoracic Surgery. We are now accelerating multi-specialty clinical adoption and scaling production to deliver more AGIBOT solutions that advance global surgical care.